SCHEMBL18263196

SCHEMBL18263196

Oc1c(-c2cc(Br)c3ccccc3c2-c2ccccc2)ccc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN22 Q9Y2R2 1/20 0.40
▸ DHFR P00374 1/20 0.39
▸ CRHBP P24387 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ LDHA P00338 1/20 0.38
▸ MPI P34949 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ESR1 P03372 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19063385 0.79 PTPN22 (0.42) PTPN22DHFRKDM4EMAPTMEN1
SCHEMBL4441768 0.79 PTPN22 (0.56) PTPN22KDM4EMAPTMEN1ALDH1A1
SCHEMBL29986541 0.79 PTPN22 (0.56) PTPN22KDM4EMAPTMEN1ALDH1A1
SCHEMBL24275657 0.78 MEN1 (0.40) DHFRKDM4EMAPTMEN1ALDH1A1
SCHEMBL19064473 0.78 PTPN22 (0.41) PTPN22DHFRKDM4EMAPTMEN1
SCHEMBL19543873 0.77 ALDH1A1 (0.51) PTPN22DHFRKDM4EMAPTMEN1
SCHEMBL17373441 0.76 CRHBP (0.50) CRHBPCRHR2KDM4EMAPTMEN1
SCHEMBL374807 0.75 PTPN22 (0.65) PTPN22ALDH1A1HPGDLDHAPOLB
SCHEMBL29401627 0.75 PTPN22 (0.65) PTPN22ALDH1A1HPGDLDHAPOLB
SCHEMBL17726752 0.74 PTPN22 (0.50) PTPN22DHFRKDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11380846-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2022-07-05 — — US disclosed
EP-3305773-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR Duk San Neolux Co., Ltd. (KR) 2018-04-11 — — EP disclosed
US-20180083197-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-03-22 — — US disclosed
US-20180083197-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-03-22 — — US disclosed
CN-107667098-A Organic electric element compound, organic electric element and its electronic installation using it 德山新勒克斯有限公司 2018-02-06 — — CN disclosed
WO-2016190600-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR 덕산네오룩스 주식회사 2016-12-01 — — WO disclosed
WO-2016190600-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR 덕산네오룩스 주식회사 2016-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11380846-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, LEF1 PTPN22 3441/4885DHFR 4450/4885CRHBP 4717/4885
US-20180083197-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, LEF1 PTPN22 3441/4885DHFR 4450/4885CRHBP 4717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback